Who Covers Wegovy and What Are the Main Income Rules?
Wegovy (semaglutide), used for weight loss and heart risk reduction, has coverage varying by insurer, with income limits often tied to government programs rather than private plans. Medicare Part D excludes weight-loss drugs like Wegovy, but covers it for cardiovascular risk reduction if criteria are met—no income limits apply there.[1] Medicaid programs set income thresholds state-by-state for obesity-related coverage.
Medicaid Income Limits for Wegovy by State
Most states cover Wegovy under Medicaid only for FDA-approved uses like preventing cardiovascular events in obese patients (approved 2024), with income eligibility based on federal poverty level (FPL). Weight-loss-only coverage is rarer.
| State Category | Income Limit Example (2024 FPL) | Coverage Notes |
|---------------|--------------------------------|---------------|
| Expansion states (e.g., CA, NY, most) | Up to 138% FPL (~$20,800 single adult) | Covers for heart risk; some add weight loss if medically necessary. CA Medi-Cal has no strict cap for adults but requires prior authorization.[2] |
| Non-expansion (e.g., TX, FL, 10 states) | Up to 100% FPL (~$15,060 single) for parents; lower/none for childless adults | Limited to heart risk; weight loss often excluded. TX Medicaid caps at 18% FPL for childless adults.[3] |
| Special cases (e.g., MA, WA) | Up to 300% FPL (~$45,180 single) | Broader coverage including BMI-based weight loss.[4] |
Check state Medicaid sites for exacts, as they update yearly. Household size adjusts limits (e.g., +$5,740 per person).
How Does Medicare Extra Help Affect Wegovy Access?
Medicare's Low-Income Subsidy (LIS, or "Extra Help") covers premiums/copays for Part D drugs like Wegovy (for heart use). Full benefits if income ≤135% FPL (~$20,340 single) and resources ≤$17,550. Partial help up to 150% FPL (~$22,590).[5] Apply via SSA.gov; it slashes out-of-pocket costs to $4.50-$10.35 per fill.
What About Private Insurance or Employer Plans?
No universal income limits—coverage depends on policy. Many exclude weight-loss drugs, requiring high copays ($1,000+/month). Employer plans via large firms (e.g., Walmart, Amazon) often cover with BMI/weight-loss thresholds, no income test. Check via insurer portal or GoodRx for copay cards reducing costs to $0-$25/month regardless of income.[6]
When Does Prior Authorization Kick In and What Income Proof Is Needed?
Insurers/Medicaid require BMI ≥30 (or ≥27 with conditions), lifestyle attempts, and doctor notes. Income verification (pay stubs, tax returns) only for Medicaid/LIS. Appeals succeed ~50% if documented.[7]
Alternatives if Over the Limit
- Manufacturer savings: Novo Nordisk card caps at $25/month for commercial insurance (income <500% FPL, ~$75,300 single).[8]
- Compounded semaglutide: $200-$400/month, no coverage needed but FDA warns of risks.
- Other drugs: Zepbound (tirzepatide) has similar coverage hurdles; some plans prefer it.
[1]: CMS.gov Medicare Coverage Database
[2]: Medicaid.gov State Profiles (CA)
[3]: Texas HHS Medicaid Eligibility
[4]: Mass.gov Health Connector (MA)
[5]: SSA.gov Extra Help
[6]: GoodRx.com Wegovy Prices
[7]: CoverMyMeds PA Data
[8]: NovoCare.com Wegovy Savings